SABRIL (vigabatrin) is a prescription medication utilized with other therapies in children and grownups 2 years old and older with refractory complex partial seizures (CPS) who have not reacted well enough to numerous other therapies and if the possible benefits surpass the threat of vision loss.
It is suggested that your doctor test your (or your youngster's) vision prior to or within 4 weeks after beginning SABRIL and at least every 3 months during therapy until SABRIL is stopped. If you or your child have any type of side impact that bothers you or that does not go away, inform your healthcare carrier.
Tell your doctor if you are expectant or plan to obtain expectant. If vision screening can not be done, your doctor might proceed suggesting SABRIL, but will certainly not be able to expect any kind of vision loss. If vision tests are refrained from doing routinely, your healthcare provider might stop prescribing SABRIL for you (or your youngster).